Valeo Pharma Inc.

TSX:VPH Stok Raporu

Piyasa değeri: CA$4.4m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Valeo Pharma Gelecekteki Büyüme

Future kriter kontrolleri 2/6

Valeo Pharma is forecast to grow revenue at 20.9% per annum. EPS is expected to grow by 64.2% per annum.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

64.2%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi48.8%
Gelir büyüme oranı20.9%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme29 Aug 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Jun 14
Market Might Still Lack Some Conviction On Valeo Pharma Inc. (TSE:VPH) Even After 55% Share Price Boost

Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Apr 20
Market Cool On Valeo Pharma Inc.'s (TSE:VPH) Revenues Pushing Shares 31% Lower

Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Mar 02
Valeo Pharma Inc. (TSE:VPH) Stocks Pounded By 33% But Not Lagging Industry On Growth Or Pricing

Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Jan 17
Investors Still Aren't Entirely Convinced By Valeo Pharma Inc.'s (TSE:VPH) Revenues Despite 68% Price Jump

Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Jun 08
Valeo Pharma Inc. (TSE:VPH) Might Not Be As Mispriced As It Looks After Plunging 29%

Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Jun 24
Analysts Have Just Cut Their Valeo Pharma Inc. (TSE:VPH) Revenue Estimates By 24%

Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Jun 17
Earnings Update: Valeo Pharma Inc. (TSE:VPH) Just Reported And Analysts Are Trimming Their Forecasts

Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

Feb 08
Have Insiders Been Buying Valeo Pharma Inc. (CSE:VPH) Shares This Year?

Kazanç ve Gelir Büyüme Tahminleri

TSX:VPH - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CAD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
10/31/202570N/AN/AN/A1
10/31/202458N/AN/AN/A1
7/31/202453-32-7-4N/A
4/30/202455-30-10-6N/A
1/31/202454-28-8-3N/A
10/31/202354-28-21-16N/A
7/31/202353-28-20-24N/A
4/30/202345-27-32-25N/A
1/31/202337-26-37-31N/A
10/31/202228-26-35-29N/A
7/31/202218-24-33-20N/A
4/30/202218-22-25-23N/A
1/31/202216-18-22-19N/A
10/31/202114-14-16-12N/A
7/31/202112-9-14-12N/A
4/30/20218-7-10-7N/A
1/31/20218-5-8-6N/A
10/31/20207-5-7-5N/A
7/31/20207-4-5-4N/A
4/30/20208-2-5-4N/A
1/31/20206-4-5-4N/A
10/31/20197-4-3-2N/A
7/31/20197-3-3-2N/A
4/30/20197-3-2-2N/A
1/31/20196-3-2-1N/A
10/31/20184-2-2-1N/A
7/31/20183-3-1-1N/A
10/31/20171-4N/A-1N/A
10/31/20161-1N/A-2N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: Insufficient data to determine if VPH's forecast earnings growth is above the savings rate (2.2%).

Kazançlar ve Piyasa: Insufficient data to determine if VPH's earnings are forecast to grow faster than the Canadian market

Yüksek Büyüme Kazançları: Insufficient data to determine if VPH's earnings are expected to grow significantly over the next 3 years.

Gelir ve Pazar: VPH's revenue (20.9% per year) is forecast to grow faster than the Canadian market (7% per year).

Yüksek Büyüme Geliri: VPH's revenue (20.9% per year) is forecast to grow faster than 20% per year.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if VPH's Return on Equity is forecast to be high in 3 years time

Büyüyen şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y